Article ; Online: Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?
2023 Volume 330, Issue 6, Page(s) 510–511
MeSH term(s) | Humans ; Alzheimer Disease/drug therapy ; Self-Injurious Behavior ; Risk Factors ; Antibodies, Monoclonal |
---|---|
Chemical Substances | Antibodies, Monoclonal |
Language | English |
Publishing date | 2023-07-17 |
Publishing country | United States |
Document type | Editorial ; Comment |
ZDB-ID | 2958-0 |
ISSN | 1538-3598 ; 0254-9077 ; 0002-9955 ; 0098-7484 |
ISSN (online) | 1538-3598 |
ISSN | 0254-9077 ; 0002-9955 ; 0098-7484 |
DOI | 10.1001/jama.2023.11704 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.88: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.